Formocortal

DB13664

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 569.06
Wujud -

Peta Jejaring Molekuler
Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

137 Data
Trastuzumab The risk or severity of neutropenia can be increased when Trastuzumab is combined with Formocortal.
Tacrolimus Tacrolimus may increase the immunosuppressive activities of Formocortal.
Phenylephrine The risk or severity of hypertension can be increased when Formocortal is combined with Phenylephrine.
Aminoglutethimide The therapeutic efficacy of Formocortal can be decreased when used in combination with Aminoglutethimide.
Sunitinib The risk or severity of hyperglycemia can be increased when Formocortal is combined with Sunitinib.
Insulin human The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin human.
Insulin lispro The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin lispro.
Insulin glargine The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin glargine.
Insulin pork The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin pork.
Troglitazone The risk or severity of hyperglycemia can be increased when Formocortal is combined with Troglitazone.
Glimepiride The risk or severity of hyperglycemia can be increased when Formocortal is combined with Glimepiride.
Sulfisoxazole The risk or severity of hyperglycemia can be increased when Formocortal is combined with Sulfisoxazole.
Disopyramide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Disopyramide.
Acarbose The risk or severity of hyperglycemia can be increased when Formocortal is combined with Acarbose.
Metformin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Metformin.
Sulfadiazine The risk or severity of hyperglycemia can be increased when Formocortal is combined with Sulfadiazine.
Rosiglitazone The risk or severity of hyperglycemia can be increased when Formocortal is combined with Rosiglitazone.
Acetohexamide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Acetohexamide.
Quinine The risk or severity of hyperglycemia can be increased when Formocortal is combined with Quinine.
Miglitol The risk or severity of hyperglycemia can be increased when Formocortal is combined with Miglitol.
Chlorpropamide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Chlorpropamide.
Nateglinide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Nateglinide.
Pentamidine The risk or severity of hyperglycemia can be increased when Formocortal is combined with Pentamidine.
Tolazamide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Tolazamide.
Repaglinide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Repaglinide.
Phenformin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Phenformin.
Glyburide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Glyburide.
Glipizide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Glipizide.
Gliclazide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Gliclazide.
Tolbutamide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Tolbutamide.
Pioglitazone The risk or severity of hyperglycemia can be increased when Formocortal is combined with Pioglitazone.
Bromocriptine The risk or severity of hyperglycemia can be increased when Formocortal is combined with Bromocriptine.
Gliquidone The risk or severity of hyperglycemia can be increased when Formocortal is combined with Gliquidone.
Mitiglinide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Mitiglinide.
Sitagliptin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Sitagliptin.
Exenatide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Exenatide.
Mecasermin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Mecasermin.
Pramlintide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Pramlintide.
Glisoxepide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Glisoxepide.
Insulin aspart The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin aspart.
Insulin detemir The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin detemir.
Insulin glulisine The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin glulisine.
Glymidine The risk or severity of hyperglycemia can be increased when Formocortal is combined with Glymidine.
AICA ribonucleotide The risk or severity of hyperglycemia can be increased when Formocortal is combined with AICA ribonucleotide.
Buformin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Buformin.
Vildagliptin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Vildagliptin.
Voglibose The risk or severity of hyperglycemia can be increased when Formocortal is combined with Voglibose.
NN344 The risk or severity of hyperglycemia can be increased when Formocortal is combined with NN344.
AMG-222 The risk or severity of hyperglycemia can be increased when Formocortal is combined with AMG-222.
Bisegliptin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Bisegliptin.
Alogliptin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Alogliptin.
Dapagliflozin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Dapagliflozin.
Saxagliptin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Saxagliptin.
Liraglutide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Liraglutide.
Gosogliptin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Gosogliptin.
Linagliptin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Linagliptin.
Canagliflozin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Canagliflozin.
Glibornuride The risk or severity of hyperglycemia can be increased when Formocortal is combined with Glibornuride.
Benfluorex The risk or severity of hyperglycemia can be increased when Formocortal is combined with Benfluorex.
Empagliflozin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Empagliflozin.
Albiglutide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Albiglutide.
Dulaglutide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Dulaglutide.
Lobeglitazone The risk or severity of hyperglycemia can be increased when Formocortal is combined with Lobeglitazone.
Netoglitazone The risk or severity of hyperglycemia can be increased when Formocortal is combined with Netoglitazone.
Rivoglitazone The risk or severity of hyperglycemia can be increased when Formocortal is combined with Rivoglitazone.
Ciglitazone The risk or severity of hyperglycemia can be increased when Formocortal is combined with Ciglitazone.
Lixisenatide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Lixisenatide.
Insulin beef The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin beef.
Insulin degludec The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin degludec.
Insulin peglispro The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin peglispro.
Insulin tregopil The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin tregopil.
Ipragliflozin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Ipragliflozin.
Dutogliptin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Dutogliptin.
Allicin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Allicin.
Tofogliflozin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Tofogliflozin.
Ertugliflozin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Ertugliflozin.
2,4-thiazolidinedione The risk or severity of hyperglycemia can be increased when Formocortal is combined with 2,4-thiazolidinedione.
Teneligliptin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Teneligliptin.
Omarigliptin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Omarigliptin.
Carmegliptin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Carmegliptin.
Gemigliptin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Gemigliptin.
Anagliptin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Anagliptin.
Evogliptin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Evogliptin.
Sotagliflozin The risk or severity of hyperglycemia can be increased when Formocortal is combined with Sotagliflozin.
Balaglitazone The risk or severity of hyperglycemia can be increased when Formocortal is combined with Balaglitazone.
Remogliflozin etabonate The risk or severity of hyperglycemia can be increased when Formocortal is combined with Remogliflozin etabonate.
Carbutamide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Carbutamide.
Guar gum The risk or severity of hyperglycemia can be increased when Formocortal is combined with Guar gum.
Metahexamide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Metahexamide.
Semaglutide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Semaglutide.
Taspoglutide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Taspoglutide.
Englitazone The risk or severity of hyperglycemia can be increased when Formocortal is combined with Englitazone.
Tirzepatide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Tirzepatide.
Gastric inhibitory polypeptide The risk or severity of hyperglycemia can be increased when Formocortal is combined with Gastric inhibitory polypeptide.
Mifepristone The risk or severity of hyperglycemia can be increased when Formocortal is combined with Mifepristone.
Sulfamethoxazole The risk or severity of hyperglycemia can be increased when Formocortal is combined with Sulfamethoxazole.
Isoniazid The serum concentration of Isoniazid can be decreased when it is combined with Formocortal.
Cyclosporine The risk or severity of adverse effects can be increased when Formocortal is combined with Cyclosporine.
Digoxin The risk or severity of adverse effects can be increased when Formocortal is combined with Digoxin.
Acetyldigitoxin The risk or severity of adverse effects can be increased when Formocortal is combined with Acetyldigitoxin.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul